IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on February 6, 2019. The filing serves to announce the Company's financial results for the fourth quarter ended December 31, 2018. The Company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the Press Release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release containing the fourth-quarter results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the full text of the Press Release (Exhibit 99.1) for specific Q4 2018 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends not present in this summary.
- Check for any updated full-year 2019 guidance or outlook provided in the press release.
- Confirm the Company's status as an emerging growth company and any related accounting election impacts.